A DNA test can reveal your genetic risk for certain diseases, whether you carry gene variants you could pass to your children, how your body processes specific medications, and a range of lifestyle traits like caffeine sensitivity. What it cannot do is predict your health future with certainty. For most common diseases, environmental and lifestyle factors explain far more of the variation in outcomes than genetics alone.
The information you get depends heavily on the type of test. A consumer kit you order online covers different ground than a clinical test ordered by a doctor, and the two differ in depth, accuracy, and what you should do with the results.
Disease Risk Estimates
Consumer DNA tests can screen for genetic variants linked to conditions like late-onset Alzheimer’s disease, Parkinson’s disease, blood clotting disorders, and a lung and liver condition called alpha-1 antitrypsin deficiency. The FDA has authorized specific reports for these conditions, each tied to particular gene variants with established links to disease.
These reports tell you whether you carry a variant associated with higher risk. They do not tell you your overall risk of developing the disease. That distinction matters. Carrying a variant linked to Parkinson’s disease, for example, raises your odds compared to someone without it, but most carriers never develop the condition. Your actual risk depends on a web of factors: other genes, your environment, your habits, and sometimes plain chance. A large study from Oxford’s Nuffield Department of Population Health found that environmental factors explained about 17% of the variation in death risk, while genetic predisposition explained less than 2%. Genetics played a larger role in dementias and breast cancer, but for diseases of the lung, heart, and liver, environment dominated.
Some tests also estimate risk for common conditions like celiac disease using low-risk gene variants. These estimates are less definitive and best understood as one data point, not a diagnosis.
Cancer Gene Screening and Its Limits
One of the most high-profile consumer DNA reports screens for variants in the BRCA1 and BRCA2 genes, which are linked to significantly higher risk of breast, ovarian, and prostate cancer. But the consumer version of this test checks for only three specific variants out of more than 1,000 known to increase cancer risk. Those three variants are most common in people of Ashkenazi Jewish descent and are rarely found in other ethnic groups.
This creates a real risk of false reassurance. A negative result on a consumer BRCA test does not mean you lack a harmful BRCA variant. It means you don’t carry those three particular variants. If you have a family history of breast or ovarian cancer, clinical-grade genetic testing covers a far broader range of mutations and is the appropriate tool. Consumer tests can catch some high-risk variants, but they were never designed to replace comprehensive cancer screening.
Carrier Status for Inherited Conditions
Carrier screening tells you whether you carry a single copy of a gene variant linked to a recessive condition. Carriers are typically healthy themselves, but if both parents carry a variant for the same condition, each pregnancy has a 25% chance of producing a child with that disease.
Common conditions included in carrier panels are cystic fibrosis, spinal muscular atrophy, sickle cell disease, thalassemia, fragile X syndrome, Tay-Sachs disease, and Canavan disease, among others. This information is most useful during family planning. Knowing your carrier status before or early in a pregnancy gives you and your partner time to assess the odds and explore options, including testing your partner or pursuing prenatal genetic counseling.
How Your Body Processes Medications
Your genes influence how quickly your liver breaks down certain drugs, which can affect whether a standard dose works well, does nothing, or causes serious side effects. This field is called pharmacogenomics, and it’s one of the most immediately practical applications of genetic testing.
A key example involves a liver enzyme that metabolizes common pain medications like codeine and tramadol. Some people are “ultra-rapid” metabolizers, meaning their bodies convert codeine into its active form much faster than normal, raising the risk of dangerous side effects. Others are “poor” metabolizers who get little benefit from the same drugs. The FDA includes genetic biomarker information on the labels of these medications, along with drugs used for ADHD and blood thinning, among others.
In 2020, the FDA cleared a consumer test to report on a gene that affects how the body handles two specific medications: one blood thinner and one antidepressant. For that gene, no confirmatory clinical testing is required. For most other pharmacogenomic results from consumer kits, confirming with a clinical test before making medication changes is still the standard recommendation.
Polygenic Risk Scores
Some DNA tests go beyond single-gene variants and calculate what’s called a polygenic risk score. Instead of looking at one gene, these scores combine the effects of thousands of small genetic variations across your genome to estimate your likelihood of developing conditions like heart disease, type 2 diabetes, or certain cancers.
These scores are purely statistical. They reflect genomic information alone and don’t account for your diet, exercise habits, medications, or any other environmental factor. A high polygenic risk score for heart disease doesn’t mean heart disease is inevitable. It means that, based on your DNA alone, your baseline risk is elevated compared to the average person. Pairing that knowledge with lifestyle information gives a more complete picture, but the score by itself is a rough probability, not a prediction.
Lifestyle and Wellness Traits
Beyond disease risk, DNA tests commonly report on traits that affect daily life. These include how efficiently you metabolize caffeine, whether you’re genetically predisposed to lactose intolerance, how your body handles certain vitamins, and traits related to sleep patterns and muscle composition. Research has identified specific genetic variants near genes involved in caffeine processing that influence how your heart rate responds to caffeine during physical activity, which helps explain why some people feel jittery after one cup of coffee while others drink three with no effect.
These trait reports are generally lower stakes than disease risk results, but they can offer useful context for habits you’ve already noticed in yourself. They’re best treated as interesting and sometimes actionable information rather than strict guidelines for how to eat or exercise.
Consumer Kits vs. Clinical Testing
Consumer DNA kits use a technology called genotyping arrays, which scan for hundreds of thousands of known genetic variants at specific positions in your DNA. This is fast and affordable but limited. It only checks the positions it’s designed to look for. Clinical genetic testing, ordered through a healthcare provider, can sequence entire genes or even your whole exome (the protein-coding portion of your genome), catching variants that consumer arrays miss entirely.
The accuracy of consumer kits is generally high for the specific variants they test, but the narrow scope means they can miss clinically significant mutations. Clinical sequencing technologies can automatically process results with less manual interpretation, reducing the chance of human error that can occur with older methods. When a consumer test flags a potentially serious result, confirming it with clinical-grade testing is important before making any medical decisions.
What Genetic Privacy Laws Cover
The Genetic Information Nondiscrimination Act (GINA) of 2008 makes it illegal for health insurers and employers to discriminate against you based on your genetic information. Health insurers cannot use your DNA results to deny coverage, set premiums, or make underwriting decisions. This protection extends to private insurers, Medicare, Medicaid, and federal employee health plans.
The gap in GINA is significant, though. It does not cover life insurance, disability insurance, or long-term care insurance. An insurer in one of these categories could, in theory, use genetic information against you. Some states have passed their own laws to fill this gap, but protections vary widely. This is worth considering before testing, particularly if you’re planning to apply for life or long-term care insurance. Once genetic data exists in a company’s database, you can’t take it back.
Making Sense of Your Results
A high-risk result on a consumer DNA test can feel alarming, but context matters. If your report shows a variant linked to a serious condition, the next step is typically a conversation with a genetic counselor. These professionals specialize in interpreting genetic results within the full picture of your family history, health status, and the specific limitations of the test you took. They can help you decide whether confirmatory clinical testing makes sense and what, if anything, you should change about your screening or prevention plan.
For carrier status results, a genetic counselor can calculate the actual odds for your future children based on both your and your partner’s results. For disease risk results, they can place the genetic finding alongside your other risk factors to help you understand what the number actually means for you, rather than in the abstract.